JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stricker, K.
Right arrow Articles by Luginbühl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stricker, K.
Right arrow Articles by Luginbühl, M.
Related Collections
Right arrow Surgery
Right arrow Complications
Right arrow Cardiovascular
Right arrow Monitoring (Cardiac)
Right arrow Monitoring (Non-cardiac)

Anesth Analg 2004;98:1184-1186
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000104585.83801.C5


GENERAL ARTICLES

Severe Hypercapnia Due to Pulmonary Embolism of Polymethylmethacrylate During Vertebroplasty

Kay Stricker, MD*, Rene Orler, MD{dagger}, Katrin Yen, MD{ddagger}, Jukka Takala, MD, PhD§, and Martin Luginbühl, MD*

Departments of *Anesthesiology and {dagger}Orthopedic Surgery, University Hospital of Bern, Switzerland; and {ddagger}Institute for Legal Medicine and §Department of Intensive Care Medicine, University of Bern, Switzerland

Address correspondence to Kay Stricker, MD, DEAA, Department of Anesthesiology, University Hospital, CH-3010 Bern, Switzerland. Address e-mail to Kay.Stricker{at}insel.ch Reprints will not be available from the authors.


    Abstract
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
Pulmonary polymethylmethacrylate embolism is a rare but potentially fatal complication of percutaneous vertebroplasty. Clinical signs are typical for pulmonary embolism: they include respiratory distress, hypotension, and decreases in end-tidal CO2. We report a case of fatal pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty that initially presented with hypertension (arterial blood pressure 190/90 mm Hg), normocardia, and hypercapnia (PaCO2 96 mm Hg), along with loss of consciousness. Several pieces of polymethylmethacrylate were found in the pulmonary vasculature at autopsy.

IMPLICATIONS: Osteoporotic spine fractures are increasingly treated by injection of bone cement into the vertebral body. Polymethylmethacrylate embolism is a rare but potentially fatal complication. We report on a case of polymethylmethacrylate embolism that was at first unrecognized because of uncharacteristic signs and symptoms.


    Introduction
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
Injection of polymethylmethacrylate (PMMA) into vertebral bodies is performed to stabilize osteoporotic fractures and for rapid pain relief (1). The procedure is minimally invasive and is mostly performed under local anesthesia and conscious sedation (2,3), even in high-risk patients (4). Although the intervention has generally been considered safe, several severe complications of this procedure have been reported; these are mainly due to embolization of fat, bone marrow, or PMMA monomer (5–7) and mostly present with severe hypotension and hypocapnia. We report on a patient with PMMA embolism during percutaneous vertebroplasty who presented with massive hypercapnia and coma.


    Case Report
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
An 83-yr-old woman (height, 158 cm; weight, 57 kg) with severe lumbar back pain due to an osteoporotic fracture of her first lumbar vertebra was scheduled for percutaneous vertebroplasty of the lumbar vertebral bodies 1 through 4. The patient had a history of chronic obstructive pulmonary disease, which was treated with 10 mg of prednisone by mouth and with inhalation therapy with ipratropium bromide and salbutamol. Her recurrent congestive heart failure was controlled with hydrochlorothiazide and amiloride and with aspirin.

On arrival in the operating room, the patient, who had not received any premedication, was monitored and turned to the prone position. During the entire 55-min procedure, she was given oxygen 6 L/min and repeated IV doses of alfentanil (250 µg). During insertion of the injection needles, arterial blood pressure was approximately 140/50 mm Hg, heart rate was 75–90 bpm, respiratory rate was 12 to 16 breaths/min, oxygen saturation was 100%, and the patient was arousable and responsive. PMMA injection was started approximately 30 min after the beginning of surgery. During the last injection of PMMA (all performed under continuous lateral fluoroscopic control), the patient became restless and moaned but remained responsive, and the anesthesiologist observed increased spontaneous respiration. This was interpreted as pain and was treated with another 250 µg of alfentanil. A gradual decrease of transcutaneous oxygen saturation to 92% and an arterial blood pressure increase to 160/65 mm Hg were observed. After termination of the PMMA injection, the patient was no longer responsive to verbal and painful stimuli; the respiratory rate was approximately 12 breaths/min, and transcutaneous oxygen saturation was still 92%. Loss of consciousness was related to alfentanil, and because the procedure was shortly before completion, it was decided to await skin closure before turning the patient to the supine position. Besides sinus tachycardia, there were no electrocardiographic changes at this time. Another 10 min later, she was turned to the supine position, and arterial blood pressure further increased to 190/90 mm Hg and heart rate to 120 bpm, whereas oxygen saturation further decreased to 80%. Assisted bag/mask ventilation was started to support spontaneous ventilation, which was approximately 7 L/min as measured with the breathing circuit and a tight-fitting face mask; this was higher than the expected minute ventilation for a patient of this weight (3.5–5 L/min). After 20 min of assisted mask ventilation with 100% oxygen (approximately 10 L/min), the patient remained unresponsive, and an arterial blood gas analysis showed a pH of 7.11, a PaO2 of 71 mm Hg, a PaCO2 of 96 mm Hg, a base excess of -3.9 mEq/L, and a bicarbonate level of 28.2 mmol/L. Although the total dose of alfentanil administered during the procedure was only 1.5 mg and although the respiratory rate and pattern were not typical for opioid-induced respiratory depression, incremental IV doses of naloxone were administered (120 µg in total). This indeed increased assisted spontaneous ventilation to 12 L/min. However, neither hypercapnia nor level of consciousness improved, and the trachea was intubated after the administration of etomidate and atracurium. The change from assisted spontaneous ventilation to positive-pressure ventilation induced a decrease in systolic arterial blood pressure from 150 to 70 mm Hg, and distended neck veins were recognized. With repeated IV boluses of noradrenaline (5–10 µg each) and adrenaline (10 and 100 µg), hemodynamic variables improved. During hypotension, an ST segment depression was noted.

A transthoracic echocardiogram demonstrated a massively dilated right ventricle. A high-resolution computed tomographic (CT) scan performed 6 h later revealed several pieces of high-contrast material (PMMA) in the pulmonary arteries of the right upper, middle, and lower lobes. At the same time, a string of PMMA could be seen that reached from the fourth lumbar vertebra to the inferior vena cava at the level of the left renal vein. During the CT scan, the patient developed pulseless electrical activity but could be successfully resuscitated within 10 min. Cardiopulmonary variables normalized within 48 h; however, the patient did not regain consciousness over the following 9 days. Several bilateral occipitotemporal infarctions were found on a cranial CT scan. Therefore, therapy was withdrawn, and the patient died within a few hours thereafter. At autopsy, the findings of the thoracoabdominal CT scan were confirmed; PMMA strings were found in the right pulmonary artery (Fig. 1), and a PMMA string exited the lumbar venous plexus and continued through the inferior vena cava (Fig. 2).



View larger version (138K):
[in this window]
[in a new window]
 
Figure 1. Methylmethacrylate string in the right upper and middle lobe arteries at autopsy (large arrow). Arteriosclerotic plaques in the right pulmonary artery as a sign of chronic pulmonary hypertension (small arrow).

 


View larger version (123K):
[in this window]
[in a new window]
 
Figure 2. Autopsy finding of a polymethylmethacrylate string (broken in two during autopsy) exiting the lumbar venous plexus at L4 and continuing in the inferior vena cava up to the level of the right kidney (arrows).

 

    Discussion
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
Previous clinical and experimental case reports on PMMA embolization with percutaneous vertebroplasty have mentioned hypotension, bradycardia, hypoxemia, and hypocapnia as major side effects (5,6,8). Conversely, the main symptoms in this case were massive hypercapnia and hypertension, along with hypoxia.

The main cause of hypercapnia was a massive increase in dead space ventilation. An increase of pulmonary arterial pressure may have led to the recruitment of previously nonperfused pulmonary vessels and thebesian veins, resulting in shunting of blood and hypoxemia. Opioid-induced hypoventilation, in contrast, had little effect, because spontaneous minute ventilation was 7 L/min and mechanical ventilation did not improve hypercapnia. Lung function and blood gas analysis at rest were not evaluated before surgery in this patient with severe chronic obstructive pulmonary disease; thus, preexisting hypercapnia cannot be differentiated from changes due to the embolism.

Current medical textbooks typically relate decreases in end-tidal CO2 during pulmonary embolism to a decrease in cardiac output and an increase of physiologic dead space (9,10). A decrease in arterial PCO2 may also occur due to hyperventilation caused by hypoxic ventilatory drive or stimulation of airway irritant receptors (10). However, not only hypocapnia, but also hypercapnia, has previously been described in clinical and experimental cases of overwhelming pulmonary thromboembolism (11,12). Detection of hypercapnia was delayed in this case, because hypertension and loss of consciousness were the only signs of embolism, whereas respiratory distress may have been attenuated by the opioids. An insufficient increase in end-tidal CO2 has been noted even after prolonged periods of severe pulmonary embolism (12). Thus, monitoring of end-expiratory CO2 with a nasal cannula would not have shortened this delay.

Clinical cases of massive pulmonary embolism with hypercarbia were associated with severe hemodynamic instability (11). However, hypertension was noted initially in our patient. Cardiac output was not measured during the procedure; however, it must have decreased after this major embolism. Thus, arterial hypertension can be explained only by a massive increase in systemic vascular resistance, possibly because of adrenergic stimulation caused by hypercapnia. After tracheal intubation and positive-pressure ventilation, venous return to the right ventricle may have decreased and pulmonary vascular resistance may have increased. Both decreased right ventricular preload and increased afterload have attenuated right heart function. Hemodynamic collapse occurred only six hours later in the CT suite, when progressive right heart failure developed. Cardiac ischemia as the main cause is unlikely, because troponin levels were only slightly increased, with a maximum of 9.7 U/L 24 hours later (normal limit <0.6 U/L), and after resolution of a temporary right bundle branch block, there were no major ST segment changes in the electrocardiogram. Additionally, at autopsy, there were diffuse atherosclerotic changes in the coronary arteries, but no infarction was found. Furthermore, the foramen ovale was closed, and there were diffuse and massive hypoxemic insults in both hemispheres of the brain, most likely dating from the resuscitation in the CT suite.

Although the procedure was performed under continuous lateral fluoroscopic control, no signs of the impending catastrophe were noted. In fact, the string of PMMA was only 2 mm thick and was invisible during fluoroscopy because of the overlying vertebral body that was already partially filled with PMMA and lying parallel to the radiograph beam. Surgical removal of PMMA from the pulmonary artery under cardiopulmonary bypass, as reported by Tozzi et al. (5), was considered in this case. However, because the cardiopulmonary situation stabilized within hours after resuscitation, and considering the age and comorbidities of the patient, the risk/benefit ratio of this intervention did not seem favorable.

In conclusion, increasing numbers of elderly patients with osteoporotic spine fractures will undergo percutaneous vertebroplasty, which is generally a fast and effective procedure. Hypertension and hypercapnia, along with loss of responsiveness, may be symptoms of severe pulmonary embolism of PMMA during this intervention. Consequently, anesthesiologists may be confronted with similar cases of atypical presentation of cement embolism. Further, in case of suspected leakage of cement, fluoroscopic projection in two levels must be performed.


    References
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 

  1. Evans AJ, Jensen ME, Kip KE, et al. Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate vertebroplasty—retrospective report of 245 cases. Radiology 2003; 226: 366–72.[Abstract/Free Full Text]
  2. Vasconcelos C, Gailloud P, Beauchamp NJ, et al. Is percutaneous vertebroplasty without pretreatment venography safe? Evaluation of 205 consecutive procedures. Am J Neuroradiol 2002; 23: 913–7.[Abstract/Free Full Text]
  3. McGraw JK, Lippert JA, Minkus KD, et al. Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow up. J Vasc Interv Radiol 2002; 13: 883–6.[ISI][Medline]
  4. Kaufmann TJ, Jensen ME, Ford G, et al. Cardiovascular effects of polymethylmethacrylate use in percutaneous vertebroplasty. Am J Neuroradiol 2002; 23: 601–4.[Abstract/Free Full Text]
  5. Tozzi P, Abdelmoumene Y, Corno AF, et al. Management of pulmonary embolism during acrylic vertebroplasty. Ann Thorac Surg 2002; 74: 1706–8.[Abstract/Free Full Text]
  6. Chen H-L, Wong C-S, Ho S-T, et al. A lethal pulmonary embolism during percutaneous vertebroplasty. Anesth Analg 2002; 95: 1060–2.[Abstract/Free Full Text]
  7. Scroop R, Eskridge J, Britz GW. Paradoxical cerebral arterial embolization of cement during intraoperative vertebroplasty. Am J Neuroradiol 2002; 23: 868–70.[Abstract/Free Full Text]
  8. Aebli N, Krebs J, Davis G, et al. Fat embolism and acute hypotension during vertebroplasty: an experimental study in sheep. Spine 2002; 27: 460–6.[ISI][Medline]
  9. Joris JL. Anesthesia for laparoscopic surgery. In: Miller RD, ed. Anesthesia. 5th ed. Philadelphia: Churchill Livingstone, 2000: 2003–23.
  10. Stoelting RK, Dierdorf SF. Anesthesia and co-existing disease. 4th ed. New York: Churchill Livingstone, 2002.
  11. Goldberg SK, Lipschutz JB, Fein AM, Lippmann ML. Hypercapnia complicating massive pulmonary embolism. Crit Care Med 1984; 12: 686–8.[ISI][Medline]
  12. Breen PH, Mazumdar B, Skinner SC. How does experimental pulmonary embolism decrease CO2 elimination? Respir Physiol 1996; 105: 217–24.[ISI][Medline]
Accepted for publication October 15, 2003.




This article has been cited by other articles:


Home page
JBJSHome page
J. Krebs, S. J. Ferguson, S. P. Hoerstrup, B. G. Goss, A. Haeberli, and N. Aebli
Influence of Bone Marrow Fat Embolism on Coagulation Activation in an Ovine Model of Vertebroplasty
J. Bone Joint Surg. Am., February 1, 2008; 90(2): 349 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. Krebs, N. Aebli, B.G. Goss, K. Wilson, R. Williams, and S.J. Ferguson
Cardiovascular Changes after Pulmonary Cement Embolism: An Experimental Study in Sheep
AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1046 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. J. Lim, S. Z. Yoon, Y.-S. Jeon, J. H. Bahk, C. S. Kim, J.-H. Lee, and J. W. Ha
An Intraatrial Thrombus and Pulmonary Thromboembolism as a Late Complication of Percutaneous Vertebroplasty
Anesth. Analg., April 1, 2007; 104(4): 924 - 926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Uemura, Y. Numaguchi, M. Matsusako, N. Kobayashi, Y. Saida, and M. Rahman
Effect on Partial Pressure of Oxygen in Arterial Blood in Percutaneous Vertebroplasty
AJNR Am. J. Neuroradiol., March 1, 2007; 28(3): 567 - 569.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
A. G. Hadjipavlou, M. N. Tzermiadianos, P. G. Katonis, and M. Szpalski
Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures and osteolytic tumours
J Bone Joint Surg Br, December 1, 2005; 87-B(12): 1595 - 1604.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stricker, K.
Right arrow Articles by Luginbühl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stricker, K.
Right arrow Articles by Luginbühl, M.
Related Collections
Right arrow Surgery
Right arrow Complications
Right arrow Cardiovascular
Right arrow Monitoring (Cardiac)
Right arrow Monitoring (Non-cardiac)


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press